Key Financial Data Key Accounting Data and Financial Indicators In Q1 2023, core financial indicators declined, with revenue down 9.19% and net profit down 26.46%, while R&D investment significantly increased by 70.43% Q1 2023 Key Financial Indicators | Indicator | Current Period (CNY) | YoY Change (%) | | :--- | :--- | :--- | | Operating Revenue | 328,723,655.39 | -9.19% | | Net Profit Attributable to Shareholders | 41,009,922.10 | -26.46% | | Net Profit Attributable to Shareholders (Excluding Non-recurring Items) | 37,721,616.53 | -19.83% | | Net Cash Flow from Operating Activities | 5,890,379.10 | N/A | | Basic Earnings Per Share (CNY/share) | 0.36 | -30.77% | | Weighted Average Return on Net Assets (%) | 2.15% | Decrease of 3.29 percentage points | | Total R&D Investment | 23,152,630.01 | 70.43% | Key Balance Sheet Indicators at Period End | Indicator | End of Current Period (CNY) | Change from Prior Year-End (%) | | :--- | :--- | :--- | | Total Assets | 2,931,362,237.34 | -1.73% | | Total Equity Attributable to Shareholders | 1,934,001,818.47 | 2.48% | Non-recurring Gains and Losses Non-recurring gains and losses totaled approximately 3.288 million CNY, mainly from fair value changes in financial assets and government subsidies, positively impacting net profit Details of Major Non-recurring Gains and Losses | Item | Current Period Amount (CNY) | | :--- | :--- | | Government Subsidies | 933,601.26 | | Gains/Losses from Fair Value Changes of Trading Financial Assets | 2,850,900.78 | | Gains/Losses from Disposal of Non-current Assets | 4,614.22 | | Net Other Non-operating Income and Expenses | -2,326.65 | | Total Non-recurring Gains and Losses (Pre-tax) | 3,869,705.39 | Analysis of Key Financial Indicator Changes Declines in net profit and EPS are attributed to reduced sales, increased R&D investment, and higher equity incentive expenses, with R&D growth reflecting a proactive strategic adjustment Reasons for Key Financial Indicator Changes | Item | Change (%) | Primary Reason | | :--- | :--- | :--- | | Net Profit Attributable to Shareholders | -26.46 | Primarily due to decreased sales, increased R&D investment, implementation of equity incentives, and higher period expenses in the current period | | Basic Earnings Per Share (CNY/share) | -30.77 | Primarily due to the decrease in net profit in the current period | | R&D Investment | 70.43 | Primarily due to increased R&D investment in the current period | Shareholder Information Shareholding Structure As of period-end, the company had 6,821 shareholders, with controlling shareholder Wu Shijun holding 28.50%, indicating a relatively concentrated yet diversified equity structure - At the end of the reporting period, the company had a total of 6,821 common shareholders7 Top Five Shareholders' Holdings | Shareholder Name | Number of Shares Held (shares) | Shareholding Percentage (%) | | :--- | :--- | :--- | | Wu Shijun | 32,250,000 | 28.50 | | Huang Bo | 7,140,000 | 6.31 | | Suzhou Lianrui Investment Management Center (Limited Partnership) | 4,000,000 | 3.53 | | Beijing Guoke Ruihua Strategic Emerging Industry Investment Fund (Limited Partnership) | 4,000,000 | 3.53 | | Suzhou Industrial Park Yuanhe Chongyuan No. 2 Equity Investment Partnership (Limited Partnership) | 2,543,400 | 2.25 | - Controlling shareholder Wu Shijun is the executive partner of Suzhou Lianrui Investment Management Center (Limited Partnership), forming a concerted action relationship9 Quarterly Financial Statements Consolidated Balance Sheet As of March 31, 2023, total assets were 2.931 billion CNY (down 1.73%), total liabilities 994 million CNY (down 9.0%), with shifts in cash, trading financial assets, and accounts payable, maintaining a stable structure and increased equity Key Balance Sheet Item Changes | Item | March 31, 2023 (CNY) | December 31, 2022 (CNY) | Change | | :--- | :--- | :--- | :--- | | Total Assets | 2,931,362,237.34 | 2,982,869,036.01 | -1.73% | | Cash and Cash Equivalents | 657,085,885.29 | 1,069,836,956.71 | -38.58% | | Trading Financial Assets | 395,573,301.36 | 0 | Newly Added | | Accounts Receivable | 524,018,392.64 | 643,679,964.88 | -18.59% | | Total Liabilities | 994,057,278.83 | 1,092,189,090.31 | -9.0% | | Accounts Payable | 420,759,905.16 | 591,182,756.70 | -28.83% | | Total Equity Attributable to Parent Company Shareholders | 1,934,001,818.47 | 1,887,286,921.49 | +2.48% | Consolidated Income Statement Q1 2023 operating revenue was 329 million CNY (down 9.19%), with significant increases in sales, general, and R&D expenses (R&D up 70.43%), resulting in a 29.0% drop in operating profit and 41.01 million CNY net profit (down 26.46%) Key Income Statement Items | Item | Q1 2023 (CNY) | Q1 2022 (CNY) | YoY Change | | :--- | :--- | :--- | :--- | | Total Operating Revenue | 328,723,655.39 | 361,986,945.87 | -9.19% | | Total Operating Costs | 287,405,365.76 | 300,646,057.41 | -4.40% | | R&D Expenses | 23,152,630.01 | 13,584,542.59 | +70.43% | | Operating Profit | 45,272,986.24 | 63,784,534.03 | -29.02% | | Total Profit | 45,270,659.59 | 63,776,534.03 | -29.02% | | Net Profit Attributable to Parent Company Shareholders | 41,009,922.10 | 55,763,444.36 | -26.46% | Consolidated Cash Flow Statement Operating cash flow improved to 5.89 million CNY (from negative 40.90 million CNY), but investing cash outflow surged to 457 million CNY for wealth management, resulting in a 430 million CNY decrease in period-end cash and cash equivalents Key Cash Flow Statement Items | Item | Q1 2023 (CNY) | Q1 2022 (CNY) | | :--- | :--- | :--- | | Net Cash Flow from Operating Activities | 5,890,379.10 | -40,904,005.65 | | Net Cash Flow from Investing Activities | -456,982,964.27 | -134,409,672.75 | | Net Cash Flow from Financing Activities | 21,938,933.08 | 49,657,556.21 | | Net Increase in Cash and Cash Equivalents | -429,783,500.16 | -125,818,866.16 | - Cash outflow from investing activities was primarily driven by 'cash paid for investments,' amounting to 790 million CNY, significantly exceeding 191 million CNY in the prior year20 - Period-end cash and cash equivalents totaled 603 million CNY, a significant decrease from 1.033 billion CNY at the beginning of the period21
瑞可达(688800) - 2023 Q1 - 季度财报